Initial and late resistance to imatinib in advanced gastrointestinal stromal tumors are predicted by different prognostic factors: a European Organisation for Research and Treatment of Cancer-Italian Sarcoma Group-Australasian Gastrointestinal Trials Group study.
暂无分享,去创建一个
M. van Glabbeke | R. Sciot | J. Verweij | D. Goldstein | A. Le Cesne | M. Schlemmer | P. Hohenberger | A. V. van Oosterom | P. Casali | I. Judson | I. Ray-Coquard | Michelle Brown | P. Hogendoorn | R. Bertulli | M. V. Van Glabbeke